Everdime Technologies, Inc.
RGST · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.02 | 11.27 | -0.01 | 10.77 |
| FCF Yield | -0.24% | -0.10% | -0.01% | 1.15% |
| EV / EBITDA | -465.60 | -1,124.91 | -1,304.58 | 0.00 |
| Quality | ||||
| ROIC | -19.94% | -29.92% | 123.85% | 0.00% |
| Gross Margin | 26.89% | 68.62% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.07 | 0.97 | 0.02 | -12.21 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -12.60% | -96.87% | -135.14% | 1,369.04% |
| Safety | ||||
| Net Debt / EBITDA | -4.53 | -3.67 | -0.89 | 0.00 |
| Interest Coverage | -30.64 | -45.71 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 438.35 | -74.75 | 0.00 | 0.00 |